genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
GEN Edge
Cytiva Picks Up Where GE Leaves Off after $21B Deal
Artificial Intelligence
Putting COVID-19 on the ‘Map’
GEN Edge
Athersys Stem Cell Therapy Targets Top Cause of COVID-19 Deaths
GEN Edge
Cellectis’ New Patent Supports CRISPR-Based T-Cell Immunotherapies
GEN Edge
Top 15 Best-Selling Drugs of 2019
News
Coronavirus
Coronavirus Picks on Some Cells More Than Others
News
Fruit Compound Reduces and Helps Repair Damage in MS Models
Bioprocessing
Akron Biotech Expands to Second US Manufacturing Facility
Coronavirus
COVID-19 and Cats: Bronx Zoo Tiger Tests Positive
Coronavirus
MERS Vaccine that Fully Protects Mice Used as Basis for Coronavirus…
Insights
All
Trends for 2020
Cell Therapy
Cell and Gene Therapy Sector Needs to Automate
Bioprocessing
The Right Start is Crucial
Bioprocessing
Going from Small to Big in Bioprocessing: Roadblocks and Their Resolution
Commentary
Understanding Glycans in COVID-19 Drug Design
A-Lists
Gilead Sciences
Catching Up to Coronavirus: Top 60 Treatments in Development
GEN Edge
Top 15 Best-Selling Drugs of 2019
Coronavirus
How to Conquer Coronavirus: Top 35 Treatments in Development
Insights
Top 10 Life Sciences Jobs Most in Demand over the Next…
GEN Edge
Ten Life Science Analysts to Watch in 2020
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Coronavirus
Coronavirus Picks on Some Cells More Than Others
Cell Therapy
Cell and Gene Therapy Sector Needs to Automate
Bioprocessing
Akron Biotech Expands to Second US Manufacturing Facility
Bioprocessing
The Right Start is Crucial
Magazine
March 2020 Vol. 40 No. 3
Expanding the CRISPR Toolbox
Commentary
Strategies for Optimizing CRISPR-Cas9 Delivery into Hard-to-Transfect Cells
March 2020 Vol. 40 No. 3
RNA Silencing Finds Its Therapeutic Voice
March 2020 Vol. 40 No. 3
Genomic Medicine Identifies Reconcilable Differences
Commentary
Hasten Genomic Medicine’s Rise with Advanced Data Management
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
Feel the Flow: Immune Cell Signaling Cascades Reveal Phenotype and Function
April 2020 Vol. 40 No.4
A New Lease on Life for shRNA
April 2020 Vol. 40 No.4
To Improve Protein Aggregation Assessments, Combine PCT and MMS
April 2020 Vol. 40 No.4
Protein Labeling Kit
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Cancer
Head and Neck Cancer
Head and Neck Cancer
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Head and Neck Cancer
BioNTech Boosting Pipeline, Manufacturing, Global Presence with $325M in Series B Financing
Head and Neck Cancer
After Patient Dies, FDA Imposes Clinical Hold on Trial of Advaxis/AstraZeneca Combination
Head and Neck Cancer
Biofilms in Tonsil Crypts May Explain HPV-Related Head and Neck Cancers
Head and Neck Cancer
PDS, Merck Agree to Phase II Combo Study with Keytruda and Versamune Immunotherapy
Head and Neck Cancer
PD-L2 Helps Predict Immunotherapy Responsiveness for Head and Neck Cancer
Head and Neck Cancer
XOMA Licenses TGFb Immuno-Oncology Program to Novartis for Up to $517M+
Head and Neck Cancer
MedImmune, 3M Partner to Develop TLR Agonist Cancer Treatments
Head and Neck Cancer
Neuroblastoma Deploys Energy-Draining Weapon against Immune System
Head and Neck Cancer
Spit and Blood Tests Successfully Detect Tumor DNA from Head and...
Head and Neck Cancer
Drug-Resistant Neuroblastoma Aided by miRNA in Tumor Microenviroment
Head and Neck Cancer
Tampering with Superenhancer Mechanism Stalls Oncoprotein’s Vicious Cycle
Head and Neck Cancer
Kadmon and NIH Agree to Evaluate Gene Therapy Approach
Head and Neck Cancer
$2.437M Grant to Fund NY Genome Center Pediatric Cancer Research Effort
Head and Neck Cancer
Memorial Sloan-Kettering to Use Sutro Technology for Neuroblastoma Research
Head and Neck Cancer
CEL-SCI, Ergomed to Co-Develop Head and Neck Cancer Candidate as Potential...
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Human papilloma virus (HPV) encased in biofilms inside tonsil crypts (pictured) may explain why the roughly 5% of HPV-infected people who develop cancer of the mouth or throat are not protected by their immune systems. Tonsil crypts with HPV are shown in green; epithelial and biofilm layers are shown in red. [Katherine Rieth. M.D.]](https://www.genengnews.com/wp-content/uploads/2018/08/161800_web6814447402-265x198.jpg "Biofilms in Tonsil Crypts May Explain HPV-Related Head and Neck Cancers")
